Solitary fibrous tumor of the pancreas: Case report and review of the literature

Table 1 Characteristics of patients with solitary fibrous tumor of the pancreas

Ref.	Sex	Age	Symptoms	Size (cm)	Location
Lüttges et al[4]	Female	50	Incidental	5.5	Body
Chatti et al[8]	Male	41	Pain	13	Body
Gardini et al[10]	Female	62	Pain	3	Head
Miyamoto et al[9]	Female	41	Pain	2	Head-body
Srinivasan et al[5]	Female	78	Pain, weight loss	5	Body
Kwon et al[7]	Male	54	Incidental	4.5	Body
Ishiwatari et al[11]	Female	58	Incidental	3	Head
Chetty et al[3]	Female	67	Incidental	2.6	Body
Sugawara et al[6]	Female	55	Incidental	7	Head
Santos et al[12]	Female	40	Incidental	3	Body
Tasdemir et al[1]	Female	24	Incidental	18.5	Head
van der Vorst et al[13]	Female	67	Pain	2.8	Uncinate process
Chen et al[14]	Female	49	Pain, distension, appetite loss	13	Head
Hwang et al[15]	Female	53	Incidental	5.2	Head
Hee Han et al[16]	Female	77	Jaundice	1.5	Head
Paramythiotis et al	Male	55	Pain	3.6	Body

Table 2 Imaging features of pancreatic Solitary fibrous tumors

Ref.	Arterial CT	Venous CT	MRI T1	MRI T2
Lüttges et al[4]	Enhanced	Enhanced
Chatti et al[8]	Enhanced	Enhanced	Hypointense	Hyperintense
Gardini et al[10]	Enhanced	Enhanced
Miyamoto et al[9]	Enhanced	Enhanced
Srinivasan et al[5]	Hyper-enhanced	Enhanced
Kwon et al[7]	Enhanced	Enhanced	Hypointense	Hyperintense
Ishiwatari et al[11]	Enhanced	Enhanced	Hypointense	Hyperintense
Chetty et al[3]	Enhanced	Enhanced
Sugawara et al[6]	Enhanced	Enhanced	Hypointense	Hyperintense
Santos et al[12]
Tasdemir et al[1]	Enhanced	Enhanced
van der Vorst et al[13]	Enhanced	Enhanced
Chen et al[14]	Enhanced	Enhanced
Hwang et al[15]	Enhanced	Enhanced	Hypointense	Hyperintense
Hee Han et al[16]	Enhanced	Enhanced	Hypointense	Hyperintense
Paramythiotis et al	Enhanced	Enhanced	Hypointense	Hyperintense

CT: Computed tomography.

Table 3 Treatment and immunohistochemistry findings

Ref.	Surgery	Immunohistochemistry
Lüttges et al[4]	Distal pancreatectomy	Positive: CD34, CD99, Bcl-2, vimentin Negative: SMA, S100
Chatti et al[8]	Enuclation	Positive: CD34, CD99 (focal), Bcl-2, SMA (focal), CD117 (focal) Negative: EMA, cytokeratin, S100
Gardini et al[10]	Traverso-longmire	Positive: CD34, CD99, Bcl-2, vimentin, smooth muscle actin (focal) Negative: Desmin, CD117, S100
Miyamoto et al[9]	Head-body junction	Positive: CD34, Bcl-2 Negative: cytokeratin, CAM 5.2, SMA, desmin, S100, CD117
Srinivasan et al[5]	Distal pancreatectomy	Positive: CD34 (focal), CD99, Bcl-2, vimentin Negative: CAM 5.2, SMA, desmin, CD117, CD10, chromogranin, S100
Kwon et al[7]	Median segmentectomy	Positive: CD34 , CD99 Negative: CD117, S100
Ishiwatari et al[11]	Pancreaticoduodenectomy	Positive: CD34, Bcl-2 Negative: S100
Chetty et al[3]	Whipple	Positive: CD34, CD99, Bcl-2
Sugawara et al[6]	Pancreaticoduodenectomy	Positive: CD34 Negative: SMA, S100, CD117, ALK, cytokeratin
Santos et al[12]	Partial pancreatectomy	Positive: CD34, b-catenin Negative: C-kit
Tasdemir et al[1]	Enuclation	Positive: CD34, vimentin, SMA (focal) Negative: S100, CD117, desmin, cytokeratin
van der Vorst et al[13]	Enuclation	Positive: CD34, CD99, Bcl-2 Negative: CD117, b-catenin
Chen et al[14]	Whipple/child	Positive: CD34, CD68, MSA, Bcl-2, Ki-67 Negative: SMA, cytokeratin, desmin, CD117, CD99, S100
Hwang et al[15]	Partial head resection	Positive: CD34, CD99, Bcl-2, SMA, CD10, ER, PR Negative: CD117, DOG-1, caldemon, desmin, EMA, S100, cytokeratin
Hee Han et al[16]	Echo-guided needle biopsy	Positive: CD34, CD99 Negative: C-kit, S100
Paramythiotis et al	Distal pancreatectomy	Positive: CD34, CD99, Bcl-2, vimentin, S100 (focal) Negative: SMA, keratin, cytokeratin, CD117, EMA and desmin

SMA: Smooth muscle actin; EMA: Epithelial membrane antigen; CAM: Anti-cytokeratin mouse monoclonal primary antibody; ALK: Anaplastic lymphoma kinase; MSA: Muscle specific actin; DOG-1: Anoctamin-1.